EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us
stamp of approval

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.

Tessera's sickle cell gene therapy wins Gates Foundation backing

Tessera Therapeutics has announced a partnership with the Bill & Melinda Gates Foundation, securing funding of up to $50m.
Orange lungs on yellow background

Respiratory infections cost UK businesses £44bn annually

A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.
Handshake on a green background

Lilly gains EU backing for drug to treat Crohn’s disease

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.
Researchers

UK improves global clinical trial ranking, but hurdles remain

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

GSK drug shows promise in multiple myeloma

A trial has shown that belantamab mafodotin can reduce the risk of death by 42% in patients with relapsed or refractory multiple myeloma.
Coin stacks

Amgen expands biomanufacturing footprint in North Carolina

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.
We’ve noticed you’re accessing
from North/South America.